✦ LIBER ✦

An open-label, single arm, phase III clinical study to evaluate the efficacy and safety of CJ smallpox vaccine in previously vaccinated healthy adults

✍ Scribed by Kim, Nak-Hyun; Kang, Yu Min; Kim, Gayeon; Choe, Pyoeng Gyun; Song, Jin Su; Lee, Kwang-Hee; Seong, Baik-Lin; Park, Wan Beom; Kim, Nam Joong; Oh, Myoung-don

Book ID: 123084395
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 499 KB
Volume: 31
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2013.08.071

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An open-label, single-arm, phase I study

An open-label, single-arm, phase I study to evaluate the safety and immunogenicity of LBVH0101, a newHaemophilus influenzaetype b tetanus toxoid conjugate vaccine, in healthy adult volunteers

✍ Namhee Kim; Gyoungjin Choi; Chi-Yeon Lim; Jae-Won Lee; Kyung-Hyo Kim; Hoan Jong 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 367 KB

A randomized, double-blind, controlled c

A randomized, double-blind, controlled clinical trial to evaluate the efficacy and safety of CJ-50300, a newly developed cell culture-derived smallpox vaccine, in healthy volunteers

✍ Hee-Chang Jang; Choong Jong Kim; Kye Hyoung Kim; Kwang-Hee Lee; Young-Ho Byun; B 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 204 KB

A phase 2, multicentre, single-arm, open

A phase 2, multicentre, single-arm, open-label study to evaluate the safety and efficacy of single-agent lenalidomide (Revlimid®) in subjects with relapsed or refractory peripheral T-cell non-Hodgkin lymphoma: The EXPECT trial

✍ Morschhauser, Franck; Fitoussi, Olivier; Haioun, Corinne; Thieblemont, Catherine 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 467 KB

A Phase 1/2 Single-Arm, Open-Label Study

A Phase 1/2 Single-Arm, Open-Label Study to Evaluate the Safety and Efficacy of Brentuximab Vedotin in Combination with Bendamustine for Patients with Hodgkin Lymphoma in the First Salvage Setting: Interim Results

✍ LaCasce, Ann; Sawas, Ahmed; Bociek, R. Gregory; Ansell, Stephen; Vose, Julie; O' 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 57 KB

A Phase III, randomized study to evaluat

A Phase III, randomized study to evaluate the immunogenicity and safety of an MF59®-adjuvanted A/H1N1 pandemic influenza vaccine in HIV-positive adults

✍ Diaz, Ricardo Sobhie; Tenore, Simone Barros; da Silva, Mônica M. Gomes; da Cunha 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 515 KB

A phase III, randomized, open-label stud

A phase III, randomized, open-label study to assess the tolerability and immunogenicity of an H5N1 influenza vaccine administered to healthy adults with a 1-, 2-, 3-, or 6-week interval between first and second doses

✍ Jiri Beran; Ibrahim A. Abdel-Messih; Jolana Raupachova; Lenka Hobzova; Elena Fra 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 137 KB